The Same Thing That Makes Ketamine a Breakthrough Antidepressant Makes It Dangerous Without Consent
A Cornell student's lawsuit alleging she was gang-raped by Chi Phi fraternity members in October 2024, after being given alcohol and ketamine that left her unable to resist or leave, has reopened a criminal investigation that initially produced no charges. On Oct 1, New York Gov. Kathy Hochul named state Attorney General Letitia James as special prosecutor, after losing confidence in the local DA's handling of the case; a separate dispute has emerged over whether phone-record preservation letters Cornell police drafted in Nov 2024 ever reached prosecutors. The allegations are disputed — some of the named students say the sex was consensual, others deny contact entirely — and nothing here is adjudicated. We're not re-reporting the legal case; PBS NewsHour and CNN are covering it in depth.
What's squarely in our lane is the pharmacology, because it's the same compound we've covered as a patent story and have an encyclopedia entry on: ketamine is an NMDA-receptor antagonist that produces dissociation, amnesia, and immobility at doses around 1.0–1.5 mg/kg IV or 3–4 mg/kg IM — the same mechanism underlying Spravato, an FDA-approved rapid-acting antidepressant for treatment-resistant depression, and the one that makes a person unable to resist or clearly recall what happened to them when it's administered without their knowledge. In a clinic, that dissociative state happens under supervision, with dosing controlled and consent established beforehand — the entire premise of ketamine-assisted therapy is that the setting and the consent are what make the drug's effects therapeutic rather than dangerous. Outside that setting, the same pharmacology is what makes ketamine one of the drugs documented in drug-facilitated sexual assault cases: a person can be conscious, compliant-looking, and have no reliable memory of it afterward.
The harm-reduction basics bear repeating because they're not abstract: never leave a drink unattended, watch drinks being poured, and know that a dissociative, amnesia-producing dose doesn't require a struggle to be incapacitating — the absence of resistance is not the same thing as consent. This is harm-reduction and pharmacology reporting, not legal commentary on an active, disputed case, and not medical advice.